NASDAQ: MURA
Mural Oncology PLC Stock Ownership - Who owns Mural Oncology?

Insider buying vs selling

Have Mural Oncology PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Maiken KesonbrookesChief Legal Officer and Secretary2025-03-051,469$3.45
$5.07kSell
Maiken KesonbrookesChief Legal Officer and Secretary2025-03-041,262$3.36
$4.24kSell
Caroline LoewChief Executive Officer2025-03-044,313$3.36
$14.49kSell
Vicki L. GoodmanChief Medical Officer2025-02-2413,186$3.89
$51.29kSell
Maiken KesonbrookesChief Legal Officer and Secretary2024-12-232,555$3.27
$8.35kSell
Caroline LoewChief Executive Officer2024-12-172,763$3.40
$9.39kSell
Vicki L. GoodmanChief Medical Officer2024-11-075,069$3.33
$16.88kSell
Adam D. CutlerChief Financial Officer2024-10-317,421$3.41
$25.31kSell
Susan AltschullerDirector2024-08-1410,000$3.21
$32.07kBuy
Maiken KesonbrookesChief Legal Officer and Secretary2024-07-182,157$3.41
$7.36kSell

1 of 2

MURA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MURA insiders and whales buy or sell their stock.

MURA Shareholders

What type of owners hold Mural Oncology PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC9.87%1,700,000$4.59MInstitution
Acorn Capital Advisors LLC7.46%1,286,079$3.47MInstitution
Solas Capital Management LLC7.37%1,269,000$3.43MInstitution
Vanguard Group Inc4.63%797,014$2.15MInstitution
Newtyn Management LLC3.31%570,000$1.54MInstitution
Prosight Management LP2.71%466,822$1.26MInstitution
Blackrock Inc1.99%343,577$927.66kInstitution
Rbf Capital LLC1.97%338,669$914.41kInstitution
Caroline Loew1.77%305,590$825.09kInsider
Renaissance Technologies LLC1.38%238,465$643.86kInstitution

1 of 3

MURA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MURA54.89%3.40%Net SellingNet Selling
STRO75.86%18.24%Net SellingNet Selling
IPSC42.30%45.63%Net SellingNet Selling
QNCX11.08%88.92%Net Buying
FBRX41.00%59.00%Net BuyingNet Selling

Mural Oncology Stock Ownership FAQ

Who owns Mural Oncology?

Mural Oncology (NASDAQ: MURA) is owned by 54.89% institutional shareholders, 3.40% Mural Oncology insiders, and 41.71% retail investors. Caroline Loew is the largest individual Mural Oncology shareholder, owning 305,590.00 shares representing 1.77% of the company. Caroline Loew's Mural Oncology shares are currently valued at $822.04k.

If you're new to stock investing, here's how to buy Mural Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.